首页> 美国卫生研究院文献>Bioinformatics >A novel bi-level meta-analysis approach: applied to biological pathway analysis
【2h】

A novel bi-level meta-analysis approach: applied to biological pathway analysis

机译:一种新颖的双层荟萃分析方法:应用于生物途径分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Motivation: The accumulation of high-throughput data in public repositories creates a pressing need for integrative analysis of multiple datasets from independent experiments. However, study heterogeneity, study bias, outliers and the lack of power of available methods present real challenge in integrating genomic data. One practical drawback of many P-value-based meta-analysis methods, including Fisher’s, Stouffer’s, minP and maxP, is that they are sensitive to outliers. Another drawback is that, because they perform just one statistical test for each individual experiment, they may not fully exploit the potentially large number of samples within each study.>Results: We propose a novel bi-level meta-analysis approach that employs the additive method and the Central Limit Theorem within each individual experiment and also across multiple experiments. We prove that the bi-level framework is robust against bias, less sensitive to outliers than other methods, and more sensitive to small changes in signal. For comparative analysis, we demonstrate that the intra-experiment analysis has more power than the equivalent statistical test performed on a single large experiment. For pathway analysis, we compare the proposed framework versus classical meta-analysis approaches (Fisher’s, Stouffer’s and the additive method) as well as against a dedicated pathway meta-analysis package (MetaPath), using 1252 samples from 21 datasets related to three human diseases, acute myeloid leukemia (9 datasets), type II diabetes (5 datasets) and Alzheimer’s disease (7 datasets). Our framework outperforms its competitors to correctly identify pathways relevant to the phenotypes. The framework is sufficiently general to be applied to any type of statistical meta-analysis.>Availability and implementation: The R scripts are available on demand from the authors.>Contact: >Supplementary Information: are available at Bioinformatics online.
机译:>动机:公共存储库中高吞吐量数据的积累迫切需要对来自独立实验的多个数据集进行综合分析。但是,研究异质性,研究偏倚,离群值和缺乏可用方法的能力对整合基因组数据提出了真正的挑战。许多基于P值的荟萃分析方法(包括Fisher,Stouffer,minP和maxP)的实际缺点之一是它们对异常值敏感。另一个缺点是,由于他们仅对每个实验进行一次统计检验,因此他们可能无法充分利用每个研究中潜在的大量样本。>结果:我们提出了一种新颖的双层元数据分析方法,在每个实验以及多个实验中都采用加法和中心极限定理。我们证明了双层框架对偏差具有鲁棒性,比其他方法对异常值更不敏感,对信号的细微变化更敏感。为了进行比较分析,我们证明,与在单个大型实验中执行的等效统计检验相比,实验内分析具有更大的功效。对于途径分析,我们使用来自与三种人类疾病相关的21个数据集的1252个样本,比较了拟议的框架与经典的荟萃分析方法(Fisher,Stouffer和加法)以及专用的途径荟萃分析套件(MetaPath)。 ,急性髓细胞性白血病(9个数据集),II型糖尿病(5个数据集)和阿尔茨海默氏病(7个数据集)。我们的框架优于竞争对手,可以正确识别与表型相关的途径。该框架具有足够的通用性,可以应用于任何类型的统计荟萃分析。>可用性和实现:R脚本可根据需要从作者那里获得。>联系方式: >补充信息:可从生物信息学在线获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号